Company
Bright Minds Biosciences Inc
CNSX:DRUG
Bright Minds Biosciences Inc harnesses its team’s decades of experience in the biology of the serotonergic system to understand the effect specific receptors have on our body. From there, the company creates new and modify existing molecules in order to reduce unwanted side effects and accentuate positive therapeutic properties. This new generation of highly targeted serotonergic drugs will be able to reach specific patient populations that the compounds of today cannot.
4 stories
Bright Minds Biosciences: A vision for “next generation” psychedelic medicines to treat neurological conditions
The company is developing the "next generation" of non-addictive psychedelic medicines to treat depression and other neurological conditions and aims to offer an alternative to today's standard treatments such as selective serotonin reuptak